Trial Profile
Comparison of indacaterol with tiotropium for stable COPD
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2013
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 11 Feb 2013 New trial record